“…Many technologies are being developed, including self-assembled spheroids/organoids 6,[43][44][45] , organ-on-a-chip 46,47 , and microtissue platforms 41,42,48 . In addition, to better mimic cardiac disease, pathological features are being introduced using hypoxia-induced apoptosis 6 , mechanical stress 49 , or varied cardiac cell ratios 50 . Recent examples have also demonstrated how the introduction of electrical barriers such as holes in healthy cardiac tissue, or fibroblast dense regions can disrupt action potential propagation 45,51 .…”